Home/Filings/4/0001571049-17-004902
4//SEC Filing

PHIBRO ANIMAL HEALTH CORP 4

Accession 0001571049-17-004902

$PAHCCIK 0001069899operating

Filed

May 10, 8:00 PM ET

Accepted

May 11, 9:03 PM ET

Size

23.6 KB

Accession

0001571049-17-004902

Insider Transaction Report

Form 4
Period: 2017-05-09
Carlson Gerald K
DirectorChief Operating Officer
Transactions
  • Exercise/Conversion

    Option to purchase Class A Common Stock

    2017-05-0910,23967,111 total
    Exercise: $11.83From: 2014-04-29Exp: 2019-02-28Class A Common Stock (10,239 underlying)
  • Exercise/Conversion

    Option to purchase Class A Common Stock

    2017-05-1043,71323,398 total
    Exercise: $11.83From: 2014-04-29Exp: 2019-02-28Class A Common Stock (43,713 underlying)
  • Exercise/Conversion

    Class A Common Stock

    2017-05-09$11.83/sh+50$59250 total
  • Sale

    Class A Common Stock

    2017-05-09$32.09/sh10,289$330,1740 total
  • Sale

    Class A Common Stock

    2017-05-10$33.55/sh43,713$1,466,5710 total
  • Sale

    Class A Common Stock

    2017-05-11$33.52/sh9,336$312,9430 total
  • Exercise/Conversion

    Option to purchase Class A Common Stock

    2017-05-09500 total
    Exercise: $11.83From: 2013-04-29Exp: 2019-02-28Class A Common Stock (50 underlying)
  • Exercise/Conversion

    Class A Common Stock

    2017-05-09$11.83/sh+10,239$121,12710,289 total
  • Exercise/Conversion

    Class A Common Stock

    2017-05-10$11.83/sh+43,713$517,12543,713 total
  • Exercise/Conversion

    Class A Common Stock

    2017-05-11$11.83/sh+9,336$110,4459,336 total
  • Exercise/Conversion

    Option to purchase Class A Common Stock

    2017-05-119,33614,062 total
    Exercise: $11.83From: 2014-04-29Exp: 2019-02-28Class A Common Stock (9,336 underlying)
Footnotes (4)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2016.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.60, inclusive.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $34.10, inclusive.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.20 to $33.75, inclusive.

Issuer

PHIBRO ANIMAL HEALTH CORP

CIK 0001069899

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001069899

Filing Metadata

Form type
4
Filed
May 10, 8:00 PM ET
Accepted
May 11, 9:03 PM ET
Size
23.6 KB